TargetMol

CK 2289

Product Code:
 
TAR-T30955
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T30955-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30955-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30955-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
CK 2289 is an inhibitor of type III cyclic 3'5' -adenosine monophosphate phosphodiesterase with potential use in the treatment of congestive heart failure.
CAS:
101183-99-7
Formula:
C15H14N4O2
Molecular Weight:
282.303
Purity:
0.98
SMILES:
CCc1[nH]c(=O)[nH]c1C(=O)c1ccc(cc1)-n1ccnc1

References

1. Chen W, Hu XY, Lu HN. [Impacts of Biochar Input on Mineralization of Native Soil Organic Carbon]. Huan Jing Ke Xue. 2015 Jun;36(6):2300-5. Chinese. PubMed PMID: 26387339. 2. Avesani CM, Draibe SA, Kamimura MA, Cendoroglo M, Pedrosa A, Castro ML, Cuppari L. Assessment of body composition by dual energy X-ray absorptiometry, skinfold thickness and creatinine kinetics in chronic kidney disease patients. Nephrol Dial Transplant. 2004 Sep;19(9):2289-95. Epub 2004 Jul 13. PubMed PMID: 15252158. 3. Greenberg SS, Paul J, Luisi A. Pharmacological comparison of CK-2289, an inodilator agent, with milrinone and enoximone. Arch Int Pharmacodyn Ther. 1991 Jan-Feb;309:103-24. PubMed PMID: 1653560.